2019 annual financial data

Prelude Therapeutics Incorporated 2019 Operating margin

Prelude Therapeutics Incorporated 2019 operating margin with verified reported…

Direct answer

Operating margin was Not calculable.

Operating income was -28,109,000 USD and net income was -27,570,000 USD.
Operating cash flow was -25,665,000 USD.

Get free Prelude Therapeutics Incorporated email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-28,109,000 USD
Net income
-27,570,000 USD
Operating cash flow
-25,665,000 USD